Goodbody Health Limited
GDBYF
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -67.89% | -42.28% | 265.58% | 820.73% | 1,049.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -67.89% | -42.28% | 265.58% | 820.73% | 1,049.19% |
| Cost of Revenue | -62.01% | -29.95% | 272.87% | 961.50% | 1,034.62% |
| Gross Profit | -73.02% | -52.36% | 258.71% | 714.85% | 1,062.22% |
| SG&A Expenses | -37.64% | -14.35% | 76.84% | 84.45% | 125.05% |
| Depreciation & Amortization | -53.17% | -56.86% | -48.83% | 28.92% | 233.30% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.06% | -23.86% | 122.00% | 204.67% | 274.34% |
| Operating Income | -864.53% | -154.20% | 110.30% | 101.18% | 112.56% |
| Income Before Tax | -57,438.46% | -435.92% | 83.06% | 34.22% | 100.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57,438.46% | -400.63% | 75.66% | 29.68% | 100.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57,438.46% | -400.63% | 75.66% | 29.68% | 100.25% |
| EBIT | -864.53% | -154.20% | 110.30% | 101.18% | 112.56% |
| EBITDA | -307.58% | -1,026.02% | 127.58% | 114.96% | 145.88% |
| EPS Basic | -40,900.00% | -380.49% | 79.79% | 41.52% | 100.12% |
| Normalized Basic EPS | -- | -417.65% | 85.81% | 96.29% | 100.00% |
| EPS Diluted | -40,900.00% | -380.49% | 79.79% | 41.52% | 100.12% |
| Normalized Diluted EPS | -- | -417.65% | 85.81% | 96.29% | 100.00% |
| Average Basic Shares Outstanding | 0.10% | 3.52% | 20.61% | 20.11% | 190.62% |
| Average Diluted Shares Outstanding | 0.10% | 3.52% | 20.61% | 20.11% | 190.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |